An experimental drug developed by a US-based team of researchers led by a Greek scientist has been shown to dramatically improve survival rates for the deadly Ebola haemorrhagic fever.
The antibody cocktail called REGN-EB3 was developed by Regeneron Pharmaceuticals where Dr Christos Kyratsous is vice president of research, infectious diseases and viral vector technologies.
The first case of West Nile fever in Bulgaria this year was reported in Montana. A 60-year-old woman with brain inflammation fell ill. The information was confirmed to the Bulgarian National Television by Prof. Dr. Todor Kantardzhiev, Director of the National Center for Infectious and Parasitic Diseases.
Currently there is no West Nile fever in Bulgaria. This was reported by BNT, quoted by Dr. Magdalena Baymakova of the Military Medical Academy.
According to the European Center for Infectious Disease Control, there are currently 33 people infected with the West Nile fever. They are in Greece, France, Hungary and Italy.
The situation had become critical when the virus had spread to the city of Goma, home to two million citizens. This city is situated on the border with Uganda, and Congo officials claim that a priest who used several false names brought the disease into the city.
A 17-year-old Italian tourist died of meningitis in a hospital in Athens on Wednesday morning, according to the initial lab results conducted by the doctors.
A Greek Air Force aircraft transferred the woman from Naxos, where she was holidaying with her family, to the Nikea hospital on Tuesday, after she developed high fever and went into septic shock. She died at the hospital.